BARCLAYS PLC - UROGEN PHARMA LTD ownership

UROGEN PHARMA LTD's ticker is URGN and the CUSIP is M96088105. A total of 68 filers reported holding UROGEN PHARMA LTD in Q1 2023. The put-call ratio across all filers is 0.13 and the average weighting 0.1%.

Quarter-by-quarter ownership
BARCLAYS PLC ownership history of UROGEN PHARMA LTD
ValueSharesWeighting
Q3 2023$48
+17.1%
3,421
-12.3%
0.00%
Q2 2023$41
-45.3%
3,901
-52.1%
0.00%
Q1 2023$75
-42.3%
8,148
-44.2%
0.00%
Q4 2022$130
-99.6%
14,599
+286.0%
0.00%
Q3 2022$31,0000.0%3,7820.0%0.00%
Q2 2022$31,000
-49.2%
3,782
-45.6%
0.00%
Q1 2022$61,000
-88.3%
6,951
-87.3%
0.00%
Q4 2021$522,000
+163.6%
54,918
+367.0%
0.00%
Q3 2021$198,000
+94.1%
11,760
+75.5%
0.00%
Q2 2021$102,000
-74.0%
6,700
-66.6%
0.00%
Q1 2021$392,000
+105.2%
20,068
+89.7%
0.00%
Q4 2020$191,000
-24.2%
10,578
-19.0%
0.00%
Q3 2020$252,000
-38.8%
13,058
-17.1%
0.00%
Q2 2020$412,000
+122.7%
15,751
+51.7%
0.00%
Q1 2020$185,000
-72.0%
10,384
-47.4%
0.00%
Q4 2019$660,000
+178.5%
19,753
+98.4%
0.00%
Q3 2019$237,000
-45.6%
9,954
-17.9%
0.00%
Q2 2019$436,000
-61.4%
12,126
-60.3%
0.00%
-100.0%
Q1 2019$1,129,000
+23.3%
30,563
+43.6%
0.00%0.0%
Q4 2018$916,000
-3.1%
21,281
+6.4%
0.00%0.0%
Q3 2018$945,000
-15.9%
20,000
-11.5%
0.00%0.0%
Q2 2018$1,124,000
-9.5%
22,600
-9.6%
0.00%0.0%
Q1 2018$1,242,00025,0000.00%
Other shareholders
UROGEN PHARMA LTD shareholders Q1 2023
NameSharesValueWeighting ↓
GREAT POINT PARTNERS LLC 2,620,545$36,713,8356.69%
Wildcat Capital Management, LLC 495,606$6,943,4402.79%
SILVERARC CAPITAL MANAGEMENT, LLC 508,883$7,129,4512.16%
Opaleye Management Inc. 320,000$4,483,2001.46%
AlphaCentric Advisors LLC 165,000$2,311,6501.31%
Soleus Capital Management, L.P. 372,000$5,211,7200.48%
EAM Investors, LLC 170,523$2,389,0270.46%
RA Capital Management 1,483,697$20,786,5950.41%
Parkman Healthcare Partners LLC 145,311$2,035,8070.37%
MENORA MIVTACHIM HOLDINGS LTD. 2,303,031$32,265,4640.29%
View complete list of UROGEN PHARMA LTD shareholders